Uses options to cap gains and cushion losses over an outcome period that begins in the year's opening quarter, Q1 in its name. The targeted result applies in full only to shares held from start to end of the period.
ARKD, the ARK DIET Q1 Buffer ETF, is a $1 million ETF whose main story is pure narrative flow.
The narrative it carries
Its main narrative, at 0.7 of its exposure.
Pure narrative flow →
Disruptive innovation, online consumers, betting and stocks chosen by social sentiment: where the retail crowd puts its money.
The band is where this narrative’s level sits among the 22 this week. QUIET means less talked about, not falling.
| # | ETF | SHARE | ASSETS | 1 YEAR | COST |
|---|---|---|---|---|---|
| 1 | ARKK | 91.7% | $7.92bn | +0.7% | 0.75% |
| 2 | IBUY | 2.0% | $120.1m | −13.8% | 0.65% |
| 3 | BUZZ | 1.7% | $102.7m | +3.4% | 0.76% |
| 4 | MILN | 1.4% | $87.1m | −14.8% | 0.50% |
| 5 | SOCL | 1.4% | $85.0m | −28.3% | 0.65% |
| 94 other ETFs | 1.8% |
Share is each ETF’s slice of the capital carrying this narrative. 1 year is market price total return; cost is the expense ratio. See all 99 ETFs on the narrative page →
Also carries: The biology trade →
Health care from drugmakers and insurers to genomics: the science that gets approved, and who pays for it.
FRI OCT 2MARKET PRICE TOTAL RETURN
| 1M | 3M | YTD | 1Y | 3Y* | 5Y* | |
|---|---|---|---|---|---|---|
| ARKD | +4.2% | +5.6% | – | – | – | – |
| Pure narrative flowits narrative | +6.7% | +9.4% | +14.8% | −0.4% | +31.0% | −3.6% |
| The marketbroad US ETFs | +0.8% | +2.6% | +14.6% | +16.8% | +22.9% | +12.9% |
1M, 3M, 1Y, 3Y, 5Y: one month to five years. YTD: year to date. * A year, annualised. A dash means the ETF has not traded for the whole period. Since it started trading on January 2, 2026: +5.5%.
$10,000 invested January 31, 2026
Total return on the market price, with each distribution reinvested on its ex-date. Not the NAV return the issuer publishes; the two differ when the ETF trades above or below the value of its holdings. The narrative is the asset-weighted return of the unlevered ETFs that carry it. The market is the asset-weighted return of broad US index ETFs. Past performance is no guarantee of future results.
FRI OCT 2MARKET PRICE TOTAL RETURN
ARKD has traded for less than a year, so how it moves against the market is not shown yet.
Where it sits in Pure narrative flow
Each dot is one of 7 unlevered ETFs whose main narrative is pure narrative flow, placed by its return (up) and how much it swung (right) over the last year.
Risk
Cost against its peers
ARKD is the 8th cheapest of 11 ETFs in pure narrative flow. The dashed line is the middle of the group, 0.75% a year.
How it is built
An unlevered long ETF. It uses options to set a defined outcome over a set period: a cap on gains and a buffer against some losses. It counts toward Share of Narrative.
Narrative exposure
Second narrative: set by a StoryVector ruling.
Common questions
What story is ARKD selling?
ARKD’s main story is pure narrative flow, which covers disruptive innovation, online consumers, betting and stocks chosen by social sentiment: where the retail crowd puts its money. Its second is the biology trade.
Run an ETF in pure narrative flow? StoryVector shows issuers where their ETFs stand against the closest rivals, every week.
Request a pilot